Topchoice Medical Corporation

Shanghai Stock Exchange 600763.SS

Topchoice Medical Corporation Revenue for the year ending December 31, 2023: USD 400.93 M

Topchoice Medical Corporation Revenue is USD 400.93 M for the year ending December 31, 2023, a 1.77% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Topchoice Medical Corporation Revenue for the year ending December 31, 2022 was USD 393.95 M, a -9.98% change year over year.
Topchoice Medical Corporation Revenue for the year ending December 31, 2021 was USD 437.63 M, a 36.82% change year over year.
Topchoice Medical Corporation Revenue for the year ending December 31, 2020 was USD 319.86 M, a 17.59% change year over year.
Topchoice Medical Corporation Revenue for the year ending December 31, 2019 was USD 272.01 M, a 21.00% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shanghai Stock Exchange: 600763.SS

Topchoice Medical Corporation

CEO	Ms. Yi Wang
IPO Date	Oct. 30, 1996
Location	China
Headquarters	Building 5
Employees	6,115
Sector	Health Care
Industries Dental Care Hospitals & Clinics Medical Instruments Pharmaceuticals

Description

Topchoice Medical Corporation provides medical services in China. It provides various specialty medical services in oral, reproductive, and ophthalmology areas; and operates dental medical institutions and assisted reproductive medical institutions. It operates approximately 32 dental hospitals; and Tongze Dental College, a non-profit educational training organization. The company was formerly known as Topchoice Medical Investment Co., Inc. and changed its name to Topchoice Medical Corporation in November 2019. Topchoice Medical Corporation was founded in 1995 and is based in Hangzhou, China.

Key trends

Past 5 years